Yes, absolutely, we're looking at anything between stage zero to stage 2 as a fairly curable rate five years out. Anything beyond that is a little bit more heavy lifting, I guess, for the patient and for the system, where the patients are experiencing more chemical toxicities from the disease progression. The system is having to respond with much more invasive treatment.
All our treatments are targeted treatments now. When a patient is diagnosed with a type of breast cancer, the type and stage will direct the treatment pathway that the patient is going to take. Certainly, the more advanced the stage of breast cancer, the more treatment will be required.
